Institutional Ownership Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX). We have compiled data on the 241 institutions that hold shares in the stock, with a total of 79.6 Million shares, which have been reported (via 13F filing form) to have a value of $4.46 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
271,747
shares
|
$15.2 Million
0.0% of portfolio
|
Q3 2024
Added 4.13%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
255,300
shares
|
$14.3 Million
0.0% of portfolio
|
Q3 2024
Added 40.58%
|
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
220,946
shares
|
$12.4 Million
0.02% of portfolio
|
Q3 2024
Reduced 29.91%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
216,117
shares
|
$12.1 Million
0.0% of portfolio
|
Q3 2024
Added 6.0%
|
|
|
Stem Point Capital LP
New York, NY |
Nov 13, 2024 Q3 2024 |
213,815
shares
|
$12 Million
3.27% of portfolio
|
Q3 2024
Reduced 61.2%
|
|
|
First Trust Advisors LP
Wheaton, IL |
Nov 13, 2024 Q3 2024 |
210,391
shares
|
$11.8 Million
0.01% of portfolio
|
Q3 2024
Added 6.82%
|
|
|
Td Asset Management Inc
|
Nov 01, 2024 Q3 2024 |
210,122
shares
|
$11.8 Million
0.01% of portfolio
|
Q3 2024
Added 2.5%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
207,712
shares
|
$11.6 Million
0.0% of portfolio
|
Q3 2024
Added 75.5%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
205,000
shares
|
$11.5 Million
0.79% of portfolio
|
Q3 2024
New holding
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
182,886
shares
|
$10.3 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.03%
|
|
|
Prudential Financial Inc
Newark, NJ |
Nov 13, 2024 Q3 2024 |
172,786
shares
|
$9.69 Million
0.01% of portfolio
|
Q3 2024
Reduced 6.98%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
168,493
shares
|
$9.45 Million
0.0% of portfolio
|
Q3 2024
Added 579.46%
|
|
|
Maplelane Capital, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
160,000
shares
|
$8.97 Million
0.5% of portfolio
|
Q2 2024
New holding
|
|
|
Decheng Capital LLC
Menlo Park, CA |
Nov 14, 2024 Q3 2024 |
157,958
shares
|
$8.86 Million
1.91% of portfolio
|
Q1 2024
New holding
|
|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
150,000
shares
|
$8.41 Million
2.87% of portfolio
|
Q3 2024
Reduced 37.5%
|
|
|
New York State Common Retirement Fund
|
Oct 28, 2024 Q3 2024 |
147,691
shares
|
$8.28 Million
0.01% of portfolio
|
Q3 2024
Reduced 11.43%
|
|
|
New Leaf Venture Partners, L.L.C.
New York, NY |
Nov 13, 2024 Q3 2024 |
141,000
shares
|
$7.9 Million
7.43% of portfolio
|
Q3 2019
Reduced 15.92%
|
|
|
Moody Aldrich Partners LLC
|
Oct 22, 2024 Q3 2024 |
139,130
shares
|
$7.8 Million
1.41% of portfolio
|
Q3 2024
Reduced 7.36%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
135,134
shares
|
$7.58 Million
0.0% of portfolio
|
Q3 2024
Added 10.88%
|
|
|
Senator Investment Group LP
New York, NY |
Nov 13, 2024 Q3 2024 |
135,000
shares
|
$7.57 Million
0.34% of portfolio
|
Q2 2024
New holding
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Nov 13, 2024 Q3 2024 |
134,087
shares
|
$7.52 Million
0.01% of portfolio
|
Q3 2024
Added 2.31%
|
|
|
Acuta Capital Partners, LLC
Belmont, CA |
Nov 14, 2024 Q3 2024 |
131,700
shares
|
$7.38 Million
6.81% of portfolio
|
Q3 2024
Reduced 2.55%
|
|
|
Swiss National Bank
Zurich, V8 |
Nov 07, 2024 Q3 2024 |
130,900
shares
|
$7.34 Million
0.0% of portfolio
|
Q3 2024
Added 0.46%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
129,592
shares
|
$7.26 Million
0.0% of portfolio
|
Q3 2024
Added 8.1%
|
|
|
Monarch Partners Asset Management LLC
|
Feb 02, 2023 Q4 2022 |
128,974
shares
|
$7.23 Million
0.72% of portfolio
|
Q4 2022
Reduced 1.44%
|